An Overview of the Development of New Vaccines for Tuberculosis

Currently, there is only one licensed vaccine against tuberculosis (TB), the Bacillus Calmette–Guérin (BCG). Despite its protective efficacy against TB in children, BCG has failed to protect adults against pulmonary TB, lacks therapeutic value, and causes complications in immunocompromised individua...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitlow, E., Mustafa, A. S., Hanif, S. N. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712106/
https://www.ncbi.nlm.nih.gov/pubmed/33027958
http://dx.doi.org/10.3390/vaccines8040586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712106/
https://www.ncbi.nlm.nih.gov/pubmed/33027958
http://dx.doi.org/10.3390/vaccines8040586

Ejemplares similares